Journal article
The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.
Abstract
PURPOSE OF REVIEW: Gastroesophageal reflux disease (GERD) is primarily a motor disorder, but its pathogenesis is multifactorial. Although gastric acid secretion is usually normal in GERD patients, treatment with proton pump inhibitors (PPIs) has become the standard of care, despite increasing awareness of their shortcomings. In this article, a new class of antisecretory drugs (namely potassium-competitive acid blockers, P-CABs), developed to …
Authors
Scarpignato C; Hunt RH
Journal
Current Opinion in Gastroenterology, Vol. 35, No. 4, pp. 344–355
Publisher
Wolters Kluwer
Publication Date
July 2019
DOI
10.1097/mog.0000000000000543
ISSN
0267-1379